JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)

SHA:603235 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,750	11,145	10,524	12,748	-	-
Market Cap Growth	3.56%	5.90%	-17.45%	-	-	-
Enterprise Value	10,596	9,508	8,230	10,499	-	-
Last Close Price	27.00	24.94	22.99	27.17	-	-
PE Ratio	19.01	17.11	22.12	20.49	-	-
PS Ratio	5.28	5.05	5.59	5.53	-	-
PB Ratio	2.46	2.42	2.49	3.14	-	-
P/TBV Ratio	2.56	2.52	2.61	3.23	-	-
P/FCF Ratio	-	-	54.36	36.83	-	-
P/OCF Ratio	21.35	22.31	14.43	21.02	-	-
EV/Sales Ratio	4.76	4.31	4.37	4.56	-	-
EV/EBITDA Ratio	13.03	12.35	15.11	15.09	-	-
EV/EBIT Ratio	16.35	15.36	20.13	18.35	-	-
EV/FCF Ratio	-45.06	-	42.51	30.33	-	-
Debt / Equity Ratio	0.08	0.03	0.03	0.00	0.18	0.30
Debt / EBITDA Ratio	0.46	0.19	0.20	0.01	0.36	0.30
Debt / FCF Ratio	-	-	0.56	0.02	0.58	0.40
Net Debt / Equity Ratio	-0.24	-0.31	-0.52	-0.56	-0.19	-0.58
Net Debt / EBITDA Ratio	-1.42	-1.83	-4.04	-3.29	-0.38	-0.59
Net Debt / FCF Ratio	4.91	2.49	-11.36	-6.62	-0.61	-0.78
Asset Turnover	0.40	0.41	0.39	0.60	0.86	0.83
Inventory Turnover	2.39	2.41	2.47	3.31	3.89	3.53
Quick Ratio	3.94	3.88	5.62	8.55	1.68	0.88
Current Ratio	5.48	5.29	6.77	10.18	2.33	1.11
Return on Equity (ROE)	13.35%	14.72%	11.48%	20.85%	48.56%	71.64%
Return on Assets (ROA)	7.23%	7.24%	5.23%	9.37%	18.39%	23.47%
Return on Invested Capital (ROIC)	15.12%	19.94%	18.12%	29.64%	72.55%	166.57%
Return on Capital Employed (ROCE)	11.90%	12.20%	8.80%	13.10%	37.90%	73.80%
Earnings Yield	5.25%	5.84%	4.52%	4.88%	-	-
FCF Yield	-2.00%	-5.09%	1.84%	2.71%	-	-
Dividend Yield	2.52%	2.73%	2.17%	2.61%	-	-
Payout Ratio	49.00%	33.81%	65.66%	1.10%	118.09%	96.20%
Buyback Yield / Dilution	0.18%	-0.11%	-5.96%	-4.68%	0.10%	-
Total Shareholder Return	2.67%	2.61%	-3.79%	-2.06%	0.10%	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.